Human big-endothelin-1 and endothelin-1 release prostacyclin via the activation of ET1 receptors in the rat perfused lung

Br J Pharmacol. 1992 Apr;105(4):773-5. doi: 10.1111/j.1476-5381.1992.tb09055.x.

Abstract

Although ET1 and ET2 binding sites were found in rat lung membranes, a selective ET1 receptor antagonist, BQ-123 (10 microM), did not displace [125I]-endothelin-1 ([125I]ET-1) from ET2 sites, illustrating the selectivity of the angatonist for ET1 receptors. In rat perfused lungs, BQ-123 (1 microM) markedly reduced the prostacyclin (PGI2) releasing properties of endothelin-1 (ET-1: 5 nM) and human big-ET-1 (100 nM) suggesting that both peptides induce the release of PGI2 via the selective activation of ET1 receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Endothelin-1
  • Endothelins / pharmacology*
  • Epoprostenol / metabolism*
  • Humans
  • In Vitro Techniques
  • Lung / drug effects*
  • Lung / metabolism
  • Male
  • Peptides, Cyclic / pharmacology
  • Protein Precursors / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Cell Surface / antagonists & inhibitors
  • Receptors, Cell Surface / drug effects
  • Receptors, Cell Surface / physiology
  • Receptors, Endothelin

Substances

  • Endothelin-1
  • Endothelins
  • Peptides, Cyclic
  • Protein Precursors
  • Receptors, Cell Surface
  • Receptors, Endothelin
  • Epoprostenol
  • cyclo(Trp-Asp-Pro-Val-Leu)